Allergies News and Research

Latest Allergies News and Research

Asthma drug accelerates desensitization in patients with food allergies to several foods

An asthma drug accelerates the process of desensitizing patients with food allergies to several foods at the same time, a new study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford shows.

3 Mar 2014

New procedure offers benefits for patients with severe asthma

Like millions of people, Jeannine Childs suffers from asthma. But unlike most, her asthma was debilitating. For years she struggled with wheezing, shortness of breath and fits of coughing so severe that they often landed her in the hospital. Nothing was really working – not lifestyle changes, not medications.

28 Feb 2014

Researchers develop ultra-precision hyperspectral camera for detection of skin cancers

VTT Technical Research Centre of Finland has developed a lightweight, handheld, ultra-precision hyperspectral camera for the detection of skin cancers and their precursors. From the surface of the skin, the camera recognises early stages of cancer that are invisible to the naked eye. Collaborators in the pilot study are the University of Jyväskylä, the Päijät-Häme Central Hospital and the Skin and Allergy Hospital of Helsinki University Central Hospital.

27 Feb 2014

Study: Direct camel-to-human transmission of MERS virus is possible in Saudi Arabia

An estimated three-quarters of camels recently surveyed in Saudi Arabia have evidence of infection with the Middle East Respiratory Syndrome coronavirus (MERS-CoV), the virus responsible for human cases of MERS.

27 Feb 2014

LA BioMed researchers awarded NIH grant to pursue new approaches for treating MRSA

With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them.

27 Feb 2014

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

The Northwestern Medicine- Sinus and Allergy Center has received a grant for more than $8.4 million from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to help advance the understanding of chronic rhinosinusitis (CRS) and the development of new methods for its treatment over the next five years.

26 Feb 2014

iCOMOS conference to explore science behind ‘One Health’ in complex environments

The University of Minnesota will present an international conference on the science behind One Health this spring in Minneapolis.

25 Feb 2014

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.

25 Feb 2014

Researchers develop early warning systems for preventing epidemics

The environment has an impact on our health. Preventing epidemics relies on activating the right counter-measures, and scientists are now trying to find out how better use of forecasting can help.

24 Feb 2014

Lone star tick bites are likely the cause of severe red meat allergies

Lone star tick bites are likely the cause of thousands of cases of severe red meat allergies that are plaguing patients in Southeastern states including Tennessee, North Carolina and Virginia and spreading up the Eastern Seaboard along with the deer population.

21 Feb 2014

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

Most people have heard of severe allergies, or anaphylaxis, to food, insect stings, drugs and other common substances, but sometimes no cause at all can be found for a person’s reaction – a condition called Idiopathic anaphylaxis.

21 Feb 2014

ACAAI experts suggest allergy sufferers to start taking medication before spring begins

With cold temperatures, snow and ice continuing to strike many regions around the country, it's hard to believe the spring allergy season is lurking right around the corner. But even in this winter mess, some of the 50 million Americans with allergies should start preparing for the spring sneezing season now before it gets too late.

21 Feb 2014

Professor receives $17M NIH grant to support IMPAACT Network

Grace Aldrovandi, MD, CM, principal investigator at The Saban Research Institute of Children's Hospital Los Angeles, has been awarded $17 million by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

20 Feb 2014

Implants made of nickel-titanium alloy are not dangerous to health, shows study

Jena (Germany) A trousers button, a coin or a watch can be dangerous for people with a nickel allergy. Approximately 1 in 10 Germans is allergic to the metal.

20 Feb 2014

Genetic profiles obtained from nasal passages guide individualized therapy, research

It has become increasingly clear in recent years that asthma comes in several variations, with different causes, different pathologies and different responses to therapy.

20 Feb 2014

OTC asthma inhaler endangers patients by encouraging substandard treatment

An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit patient education and advocacy organization.

20 Feb 2014

Eleven Biotherapeutics announces first pivotal Phase 3 clinical study of EBI-005 for treatment of DED

Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that patient randomization and dosing are underway in the Company's first pivotal Phase 3 clinical study of EBI-005 for the treatment of moderate to severe dry eye disease (DED), the OASIS study (A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Control In Subjects With Moderate to Severe Dry Eye Disease).

19 Feb 2014

Taste receptors act as first line sentinels against infection in upper airway

The body uses mucus as a protective barrier to defend against pathogens, toxins, and allergens in the upper respiratory tract that can lead to such conditions as chronic sinusitis.

19 Feb 2014

Polyplus-transfection grants research license to NIH for PEI-mediated transfection applications

Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, announces today that it has granted two agencies of the United States National Institutes of Health a non-exclusive, research license to use Polyethylenimine (PEI) for in vitro transfection applications. The two agencies are the National Institute of Allergy and Infectious Diseases and the National Cancer Institute.

17 Feb 2014

Study shows vitamin D may provide some relief for patients with chronic hives

A study by researchers at the University of Nebraska Medical Center shows vitamin D as an add-on therapy could provide some relief for chronic hives, a condition with no cure and few treatment options.

17 Feb 2014

Allergies News and Research

Latest Allergies News and Research

Asthma drug accelerates desensitization in patients with food allergies to several foods

New procedure offers benefits for patients with severe asthma

Researchers develop ultra-precision hyperspectral camera for detection of skin cancers

Study: Direct camel-to-human transmission of MERS virus is possible in Saudi Arabia

LA BioMed researchers awarded NIH grant to pursue new approaches for treating MRSA

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

iCOMOS conference to explore science behind ‘One Health’ in complex environments

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Researchers develop early warning systems for preventing epidemics

Lone star tick bites are likely the cause of severe red meat allergies

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

ACAAI experts suggest allergy sufferers to start taking medication before spring begins

Professor receives $17M NIH grant to support IMPAACT Network

Implants made of nickel-titanium alloy are not dangerous to health, shows study

Genetic profiles obtained from nasal passages guide individualized therapy, research

OTC asthma inhaler endangers patients by encouraging substandard treatment

Eleven Biotherapeutics announces first pivotal Phase 3 clinical study of EBI-005 for treatment of DED

Taste receptors act as first line sentinels against infection in upper airway

Polyplus-transfection grants research license to NIH for PEI-mediated transfection applications

Study shows vitamin D may provide some relief for patients with chronic hives

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Allergies News and Research

Latest Allergies News and Research

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Newsletters you may be interested in